Volume 20 Issue 7
Jul.  2022
Turn off MathJax
Article Contents
CHEN Jia, CHEN Xiang-yu, LUO Song. Effects of argatroban combined with butylphthalide soft capsule on NIHSS score and quality of life in patients with perforating cerebral infarction[J]. Chinese Journal of General Practice, 2022, 20(7): 1135-1138. doi: 10.16766/j.cnki.issn.1674-4152.002541
Citation: CHEN Jia, CHEN Xiang-yu, LUO Song. Effects of argatroban combined with butylphthalide soft capsule on NIHSS score and quality of life in patients with perforating cerebral infarction[J]. Chinese Journal of General Practice, 2022, 20(7): 1135-1138. doi: 10.16766/j.cnki.issn.1674-4152.002541

Effects of argatroban combined with butylphthalide soft capsule on NIHSS score and quality of life in patients with perforating cerebral infarction

doi: 10.16766/j.cnki.issn.1674-4152.002541
Funds:

 KJ2019A0364

  • Received Date: 2021-08-25
    Available Online: 2022-09-23
  •   Objective  To determine the clinical effect of argatroban combined with butylphthalide soft capsules in the treatment of perforating cerebral infarction.  Methods  Seventy-six patients with perforating cerebral infarction were enrolled and randomly divided into the study group (n=39) and control group (n=37). The patients in the control group were given clopidogrel bisulphate tablets on the basis of conventional therapy, and those in the study group were given argatroban and butylphthalide soft capsules. The National Institute of Health stroke scale (NIHSS) score, Barthel index (BI), incidence of progressive muscular dystrophy (PMD) and neurological recovery (mRS score) were compared. The World Health Organization Quality of Life-100 was used to evaluate the quality of life.  Results  At the 12th week, the NIHSS scores of the study group and control group were (4.1±1.7) points and (5.6±1.5) points, respectively. The study group had a significantly lower score (P < 0.05). The BI scores of the study group and control group were (76.9±16.3) points and (68.3±13.7) points, respectively. The study group had a significantly higher score (P < 0.05). The mRS scores of the study group and control group were (2.6±0.6) points and (2.9±0.8) points, respectively, with no statistical difference (P > 0.05). The results of the quality of life evaluation showed that the scores of physiological health, social relations and independent ability of the study group were significantly higher than those of the control group (all P < 0.05).  Conclusion  Argatroban combined with butylphthalide soft capsules has a good therapeutic effect and high application value on patients with perforating cerebral infarction.

     

  • loading
  • [1]
    谷欣荣, 张晓中. 脑梗死患者血清同型半胱氨酸水平与患者病情严重程度的关系[J]. 安徽医学, 2017, 38(12): 1597-1599. doi: 10.3969/j.issn.1000-0399.2017.12.029

    GU X R, ZHANG X Z. Erum homocysteine level and condition of patients with cerebral infarction Relationship of severity[J]. Anhui Medical Journal, 2017, 38(12): 1597-1599. doi: 10.3969/j.issn.1000-0399.2017.12.029
    [2]
    王冬欣, 李易明, 张志涛, 等. 血浆同型半胱氨酸水平与中国缺血性卒中亚型关系的研究[J]. 河北医药, 2018, 40(14): 2193-2142. doi: 10.3969/j.issn.1002-7386.2018.14.028

    WANG D X, LI Y M, ZHANG Z T, et al. Correlation between Chinese ischemic stroke subtype and the levels of plasma homocysteine[J]. Hebei Medical Journal, 2018, 40(14): 2193-2142. doi: 10.3969/j.issn.1002-7386.2018.14.028
    [3]
    潘能毅, 武志全, 林树楷, 等. 血液生化指标主成分回归模型用于脑梗死患者CISS分型[J]. 贵阳医学院学报, 2020, 45(1): 237-242. https://www.cnki.com.cn/Article/CJFDTOTAL-GYYB202002022.htm

    AN N Y, WU Z Q, LIN S K, et al. Principal Component Regression Model of Blood Biochemical Index for CISS Classification of Cerebral Infarction Patients[J]. Journal of Guiyang Medical College, 2020, 45(1): 237-242. https://www.cnki.com.cn/Article/CJFDTOTAL-GYYB202002022.htm
    [4]
    TAKEUCHI M, MIYASHITA K, NAKAGAWARA J, et al. Analysis of factors associated with progression and long-term outcomes of penetrating artery territory infarction: A retrospective study[J]. J Stroke Cerebrovasc Dis, 2016, 25(8): 1952-1959. doi: 10.1016/j.jstrokecerebrovasdis.2016.04.007
    [5]
    田婷, 关智媛, 石正洪, 等. 复发性缺血性脑卒中的危险因素、严重程度及短期预后分析[J]. 中国康复理论与实践, 2016, 22(2): 172-177. doi: 10.3969/j.issn.1006-9771.2016.02.011

    TIAN T, GUAN Z Y, SHI Z H, et al. Risk Factors, Severity and Short-term Outcome of Recurrent Ischemic Stroke[J]. Chinese Journal of Rehabilitation Theory and Practice, 2016, 22(2): 172-177. doi: 10.3969/j.issn.1006-9771.2016.02.011
    [6]
    SUN S Y, WANG Y Q, WANG Y G, et al. Lipid and hyperglycemia factors in first-ever penetrating artery infarction, a comparison between different subtypes[J]. Brain Behav, 2017, 7(6): e00694. DOI: 10.1002/brb3.694.
    [7]
    FRANCESCA P, PUNITHA A, MARCUS M, et al. Short-versus long-term dual anti-platelet therapy (DAPT) in Secondary prevention for ischaemic stroke-a network meta-analysis[J]. Eur Heart J Qual Care Clin Outcomes, 2019, 5(4): 298-309. doi: 10.1093/ehjqcco/qcz024
    [8]
    LIU Y, LI F, SUN H W, et al. Combined prognostic significance of D-dimer level and platelet count in acute ischemic stroke[J]. Thrombosis Research, 2020, 194: 142-149. doi: 10.1016/j.thromres.2020.05.021
    [9]
    SCALAMBRINO E, PADOVAN L, CHANTARANGKUL V, et al. Responsiveness of the activated partial thromboplastin time and dilute thrombin time to argatroban: Results of an in vitro study[J]. Int J Lab Hematol, 2020, 42(2 suppl): e128-e131.
    [10]
    吉智, 范秀博. 注射用红花黄色素联合阿加曲班治疗急性脑梗死的临床研究[J]. 现代药物与临床, 2016, 31(2): 158-162. https://www.cnki.com.cn/Article/CJFDTOTAL-GWZW201602007.htm

    JI Z, FAN X B. Clinical study of Safflower Yellow for injection combined with argatroban in treatment of acute cerebral infarction[J]. Drugs & Clinic, 2016, 31(2): 158-162. https://www.cnki.com.cn/Article/CJFDTOTAL-GWZW201602007.htm
    [11]
    苏观利, 黎永仙, 王华, 等. 阿加曲班、氯吡格雷与丁苯酞联合治疗进展性脑梗死的疗效及安全性研究[J]. 临床急诊杂志, 2017, 18(10): 775-778. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZLC201710015.htm

    SU G L, LI Y X, WANG H, et al. Efficacy and safety of combined use of argatroban and clopidogrel and butylphthalide in the treatment of progressive cerebral infarction[J]. Journal of Clinical Emergency, 2017, 18(10): 775-778. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZLC201710015.htm
    [12]
    WANG X L, WANG L N, HUANG Z J, et al. Synthesis and biological evaluation of nitric oxide releasing derivatives of 6-amino-3-n-butylphthalide as potential antiplatelet agents[J]. Bioorg Med Chem Lett, 2013, 23: 1985-1988. doi: 10.1016/j.bmcl.2013.02.035
    [13]
    张伟平, 屈洪党, 许力. 丁苯酞注射液对脑梗死患者血清细胞凋亡因子水平的影响[J]. 中华全科医学, 2019, 17(7): 1087-1089, 1190. doi: 10.16766/j.cnki.issn.1674-4152.000869

    ZHANG W P, QU H D, XU L. Effect of butylphthalide injection on the serum level of apoptosis-related factors in patients with cerebral infarction[J]. Chinese Journal of General Practice, 2019, 17(7): 1087-1089, 1190. doi: 10.16766/j.cnki.issn.1674-4152.000869
    [14]
    陆冰, 刘洲, 林智君, 等. 丁苯酞对血管性痴呆患者脑循环动力学及血管内皮功能的影响[J]. 浙江医学, 2018, 40(13): 1443-1446, 1450. doi: 10.12056/j.issn.1006-2785.2018.40.13.2018-173

    LU B, LI Z, LIN Z J, et al. Effects of butylphthalide on cerebral circulation dynamics and vascular endothelial function in patients with vascular dementia[J]. Zhejiang Medical Journal, 2018, 40(13): 1443-1446, 1450. doi: 10.12056/j.issn.1006-2785.2018.40.13.2018-173
    [15]
    顾媛媛, 冯来会. 丁苯酞软胶囊联合高压氧对老年急性脑梗死患者转化生长因子β1、尿酸水平及生活质量的影响[J]. 中国老年学杂志, 2019, 39(10): 2322-2326. doi: 10.3969/j.issn.1005-9202.2019.10.007

    GU Y Y, FENG L H. Effect of butylphthalide soft capsule combined with hyperbaric oxygen on transforming growth factor-β1, uric acid level and quality of life in elderly patients with acute cerebral infarction[J]. Chinese Journal of Gerontology, 2019, 39(10): 2322-2326. doi: 10.3969/j.issn.1005-9202.2019.10.007
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(4)

    Article Metrics

    Article views (241) PDF downloads(1) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return